TY - JOUR
T1 - Clinically isolated syndromes suggestive of multiple sclerosis, part 1
T2 - natural history, pathogenesis, diagnosis, and prognosis
AU - Miller, D
AU - Barkhof, F
AU - Montalban, X
AU - Thompson, A
AU - Filippi, M
PY - 2005/5
Y1 - 2005/5
N2 - In 85% of young adults with multiple sclerosis (MS), onset is a subacute clinically isolated syndrome (CIS) of the optic nerves, brainstem, or spinal cord. Methods of assessing the prognosis for patients who present with a CIS have been sought, because only 30-70% of patients with a CIS develop MS. When clinically silent brain lesions are seen on MRI, the likelihood of developing MS is high. MS can be diagnosed within 3 months of CIS presentation with certain MRI and CSF criteria. Disability from MS is less likely in patients with a CIS of optic neuritis or sensory symptoms only, few or no MRI lesions, a long period to the first relapse, and no disability after the first 5 years. Development of more reliable prognostic markers will enable new treatments to be targeted for those who are most likely to benefit. We encourage continued clinical and laboratory assessment of patients with a CIS.
AB - In 85% of young adults with multiple sclerosis (MS), onset is a subacute clinically isolated syndrome (CIS) of the optic nerves, brainstem, or spinal cord. Methods of assessing the prognosis for patients who present with a CIS have been sought, because only 30-70% of patients with a CIS develop MS. When clinically silent brain lesions are seen on MRI, the likelihood of developing MS is high. MS can be diagnosed within 3 months of CIS presentation with certain MRI and CSF criteria. Disability from MS is less likely in patients with a CIS of optic neuritis or sensory symptoms only, few or no MRI lesions, a long period to the first relapse, and no disability after the first 5 years. Development of more reliable prognostic markers will enable new treatments to be targeted for those who are most likely to benefit. We encourage continued clinical and laboratory assessment of patients with a CIS.
KW - Acute optic neuritis
KW - Term-follow-up
KW - 1st demyelinating event
KW - Spinal-cord syndromes
KW - Brain-stem
KW - Isolated lesions
KW - Cognitive impairment
KW - Predict conversion
KW - Interferon beta-1a
KW - Evoked-potentials
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uab_pure&SrcAuth=WosAPI&KeyUT=WOS:000228589900019&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1016/S1474-4422(05)70071-5
DO - 10.1016/S1474-4422(05)70071-5
M3 - Article
C2 - 15847841
SN - 1474-4422
VL - 4
SP - 281
EP - 288
JO - The Lancet Neurology
JF - The Lancet Neurology
IS - 5
ER -